Short-term outcomes of mirogabalin in patients with peripheral neuropathic pain: a retrospective study

BACKGROUND: Mirogabalin, which is approved for the treatment of peripheral neuropathic pain in Japan, is a ligand for the α2δ subunit of voltage-gated calcium channels. Both pregabalin and mirogabalin act as nonselective ligands at the α2δ-1 and α2δ-2 subunits. Mirogabalin has a unique binding profi...

Descripción completa

Detalles Bibliográficos
Autores principales: Tetsunaga, Tomoko, Tetsunaga, Tomonori, Nishida, Keiichiro, Misawa, Haruo, Takigawa, Tomoyuki, Yamane, Kentaro, Tsuji, Hironori, Takei, Yoshitaka, Ozaki, Toshifumi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2020
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7249688/
https://www.ncbi.nlm.nih.gov/pubmed/32456647
http://dx.doi.org/10.1186/s13018-020-01709-3

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7249688/
https://www.ncbi.nlm.nih.gov/pubmed/32456647
http://dx.doi.org/10.1186/s13018-020-01709-3

Ejemplares similares